Sunday, 2 January 2022

Buying Tesla? Wait until you see this…

Dear Reader, 

I don't know if you're aware of this or not... 

But an absolute stock market frenzy has erupted in electric vehicle (EV) companies this year. 

I began recommending companies in this space earlier this year... and the recent gains seen in this sector are ridiculous... 

  • An Ohio company called Workhorse soared roughly 500% in as little as two months.
  • Tesla, of course, has shot up nearly 400% since the start of the year.
  • A company called Green Power Motor has shot up as much as 1,000% since the start of the year.
  • And a slew of other EV companies have shot up 71% in just two days... 104% in a single day... and 46% in just one day.

But here's the remarkable thing... 

There's an even bigger story on the horizon, involving electric vehicles, and almost no one is talking about what's coming next. 

It's a development that I think will potentially produce even bigger potential long-term gains and could truly transform our country in so many ways. 

I strongly encourage you to get the full story and the facts for yourself

This is a huge trend that's certainly going to impact your life and could potentially make you a fortune. 

My team and I have just posted an updated, thorough, and free analysis, complete with videos, photos, stock charts, and our #1 favorite investment in this space... all revealed for free. 

Check it out today on our website here... 

Regards, 

Whitney Tilson 
Founder, Empire Financial Research 

P.S. There's NO subscription, NO credit card, and NO e-mail address required to get access to my analysis and my #1 top stock pick in this booming trend. Click here for your free access… 

UpTrendAlerts, 711 SW 24th Ave, Boynton Beach, FL 33435, United States
You may unsubscribe or change your contact details at any time.

No comments:

Post a Comment

Breaking News Hits Wire: TC BioPharm (NASDAQ: TCBP) Makes Approx 189% Early Move

  *Sponsored After an Approximate 1,041% Move in Under 3 Months From a Recent BioPharma Profile, Ou...